StonvexLoading…
StonvexStonvexStonvexCore line items from WEYS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $276.17M | $290.29M | $318.05M | $351.74M |
Operating Income | $29.17M | $36.61M | $41.02M | $40.37M |
Net Income | $23.08M | $30.32M | $30.19M | $29.54M |
EPS (Diluted) | $2.41 | $3.16 | $3.17 | $3.07 |
Total Assets | $319.67M | $324.09M | $309.34M | $326.62M |
Total Liabilities | $80.10M | $78.50M | $64.85M | $102.72M |
Cash & Equivalents | $96.01M | $70.96M | $69.31M | $16.88M |
Free Cash Flow OCF − CapEx | $35.50M | $36.34M | $95.32M | $-32.25M |
Shares Outstanding | 9.53M | 9.64M | 9.50M | 9.58M |